Case Detail

Novartis Corp. v. Federal Trade Commission
On October 29, 1999, WLF filed a brief urging the U.S. Court of Appeals for the D.C. Circuit to set aside an order by the Federal Trade Commission (FTC) compelling Novartis Corporation, a pharmaceutical company, to include a governmentally-dictated message in its advertising. The FTC filed a complaint against Novartis, the manufacturer of Doan's Pills, alleging that advertisements for Doan's had been misleading insofar as they suggested that Doan's offers more effective relief for back pain than other pain relievers. After an independent review, WLF urged that the court of appeals would find no factual basis on which to conclude that corrective advertising was warranted.
Case Status:
  • Welcome to the Washington Legal Foundation
  • 2009 Massachusetts Ave., NW
    Washington, DC 20036
  • info@wlf.org  |  ph. 202-588-0302
    ©2018 WLF All Rights Reserved